A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial

Background: Chronic lymphocytic leukemia (CLL) is characterized by accumulation of B cells in blood, lymphoid tissues and bone marrow. Addition of rituximab to CLL chemotherapy regimens has been associated with improved survival. The aim of this study was to establish efficacy and safety of Zytux™ i...

Descripción completa

Detalles Bibliográficos
Autores principales: Toogeh, Gholamreza, Faranoush, Mohammad, Razavi, Seyed Mohsen, Jalaeikhoo, Hassan, Allahyari, Abolghasem, Ravanbod, Mohammad Reza, Zarrabi, Fariba, Fallahazad, Vahid, Rezaei Darzi, Ehsan, Alizadeh Fard, Shadi Sadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141434/
https://www.ncbi.nlm.nih.gov/pubmed/30233768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141434/
https://www.ncbi.nlm.nih.gov/pubmed/30233768

Ejemplares similares